Clin Mol Hepatol.
2023 Apr;29(2):390-393. 10.3350/cmh.2023.0059.
Screening strategies for non-alcoholic fatty liver disease: a holistic approach is needed
- Affiliations
-
- 1University of Cologne, Faculty of Medicine, and University Hospital Cologne, Department of Gastroenterology and Hepatology, Cologne, Germany
- 2Department of Hepatology and Gastroenterology, Campus Virchow Clinic, Charité University Medicine, Berlin, Germany
- 3University of Cologne, Faculty of Medicine, and University Hospital Cologne, Hypertension Center, Cologne, Germany
- KMID: 2541425
- DOI: http://doi.org/10.3350/cmh.2023.0059
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Clinical impact of nonalcoholic fatty liver disease on other medical diseases
- Should you advocate for hepatocellular carcinomasurveillance in patients with alcohol-related liverdisease or non-alcoholic fatty liver disease?
- How to optimize the outcome of liver transplantation for non-alcoholic fatty liver disease
- Experimental model and novel therapeutic targets for non-alcoholic fatty liver disease development
- A Case of Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease
